XML 34 R15.htm IDEA: XBRL DOCUMENT
v3.19.1

NET LOSS PER SHARE | 3 Months Ended
--- | ---
Mar. 31, 2019
NET LOSS PER SHARE |
NET LOSS PER SHARE | 5 - NET LOSS PER SHARE The computation of basic net loss per share is based on the weighted-average number of common shares outstanding during the reporting period. The computation of diluted net loss per share assumes the vesting of nonvested stock awards and the exercise of stock options (refer to Note 15 — Stock-Based Compensation), for which the assumed proceeds upon vesting are deemed to be the amount of compensation cost attributable to future services and are not yet recognized using the treasury stock method, to the extent dilutive. There were 242,772 restricted stock units and 496,148 stock options excluded from the computation of diluted net loss per share during the three months ended March 31, 2019 because they were anti-dilutive. There were 264,367 shares of restricted stock and restricted stock units and 255,608 stock options excluded from the computation of diluted net loss per share during the three months ended March 31, 2018 because they were anti-dilutive. (refer to Note 15 — Stock-Based Compensation) The Company’s diluted net loss per share will also reflect the assumed conversion of the equity warrants issued when the Company emerged from bankruptcy on July 9, 2014 (the “Effective Date”) and MIP Warrants issued by the Company (refer to Note 15 — Stock-Based Compensation) if the impact is dilutive under the treasury stock method. The equity warrants have a 7-year term that commenced on the day following the Effective Date and are exercisable for one tenth of a share of the Company’s common stock. There were no unvested MIP Warrants and 3,936,761 equity warrants excluded from the computation of diluted net loss per share during the three months ended March 31, 2019 and 2018 because they were anti-dilutive. The components of the denominator for the calculation of basic and diluted net loss per share are as follows:
|  | For the Three Months Ended |
|  | March 31, |
|  | 2019 |  | 2018 |
Common shares outstanding, basic: |  |  |  |  |
Weighted-average common shares outstanding, basic |  | 41,726,106 |  | 34,577,990 |
Common shares outstanding, diluted: |  |  |  |  |
Weighted-average common shares outstanding, basic |  | 41,726,106 |  | 34,577,990 |
Dilutive effect of warrants |  | — |  | — |
Dilutive effect of stock options |  | — |  | — |
Dilutive effect of restricted stock awards |  | — |  | — |
Weighted-average common shares outstanding, diluted |  | 41,726,106 |  | 34,577,990 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration